Amanote Research

Amanote Research

    RegisterSign In

Pcn244 - Real-World Evidence on the Utilisation of Regorafenib in Ireland

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.326
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
Date

October 1, 2018

Authors
L. Trela-LarsenC. UsherL. McCullaghC. Walsh
Publisher

Elsevier BV


Related search

Evidence-Based Practice in the Real World

Evidence and Policy
Sports MedicineCardiologySocial SciencesOrthopedicsCardiovascular MedicinePhysiology
2005English

22PIpilimumab for Advanced Melanoma in the Real World: The Northern Ireland Experience

Annals of Oncology
MedicineOncologyHematology
2017English

Real-World Evidence Research Based on Big Data

Onkologe
OncologyHematology
2018English

The World of Real Research. Commentary On... Research in the Real World

Psychiatric Bulletin
2006English

The Inclusion of Real World Evidence in Clinical Development Planning

Trials
MedicinePharmacology
2018English

Report on the Current Status of the Use of Real‐world Data (RWD) and Real‐world Evidence (RWE) in Drug Development and Regulation

British Journal of Clinical Pharmacology
Pharmacology
2019English

Real‐World Adherence in Patients With Metastatic Colorectal Cancer Treated With Trifluridine Plus Tipiracil or Regorafenib

Oncologist
Cancer ResearchMedicineOncology
2019English

Study Verifies Value of Real-World Evidence

Cancer Discovery
Oncology
2019English

FDA to Consider Real-World Evidence

Cancer Discovery
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy